OTC - ACTIVE INGREDIENT SECTION
Active Ingredient: Purpose
Salicylic Acid 2.0% Acne Treatment
Active Ingredient: Purpose
Salicylic Acid 2.0% Acne Treatment
For the treatment of Acne
Keep out of reach of children.If swallowed, get medical help or contact a Poison Control Center right away
Using other topical acne medication at the same tim or immediately following the use of this product may increase dryness or irritation of the skin. If this occurs, only one medication should be used unless directed by a doctor
Cleanse skin thoroughly before applying. Cover the entire affected area with a thing layer 1 to 3 times daily or as directed by a doctor. If bothersome dryness or peeling occurs, reduce application to once a day or every other day.
SD Alcohol 40-B, Aqua/Water/Eau, Hamamelis Virginiana (Witch Hazel) Bark/Leaf/Twig Extract, Polyacrylate Crosspolymer 6, Laminaria Saccarina Extract, Thermus Thermophillus Ferment, Opuntia Ficus-Indica Stem Extract, Sea Whip Extract, Bisabolol, Glycerin, Pentylene Glycol, Butylene Glycol, Propylene Glycol, Aminomethyl Propanol, 4-t-Butylcyclohexanol, Hydroxyethylcellulose, Hydroxymethoxyphenyl Decanone, Benzalkonium Chloride
ACNE DEFENSE
SPOT TREATMENT
ACNE TREATMENT GEL
merle norman
14g e
NET WT. .50 OZ.
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 57627-201 | 57627-201-01, 57627-201-02 |
Every source-derived ingredient row is available through these pages.
| Version | Effective date | Source | Hydrated |
|---|---|---|---|
| 5 | 2025-11-18 | full-release | 2026-06-01 01:16:49 |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 43e5977e-e84f-e303-e063-6394a90aca85 | c6296d3a-fabe-4a8f-91e8-cac2ae6ff926 | 2025-11-18 | Warnings | c6296d3a-fabe-4a8f-91e8-cac2ae6ff926 |
Adverse event summaries are temporarily unavailable. Other product information remains available.